Raymond James Financial Services Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $9.51K | Sell |
|
|||||
|
2024
Q2 | $12.4K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $34K | Sell |
|
|||||
|
2021
Q3 | $36K | Sell |
|
|||||
|
2021
Q2 | $41K | Buy |
|
|||||
|
2021
Q1 | $33K | Buy |
|
|||||
|
2020
Q4 | $21K | Sell |
|
|||||
|
2020
Q3 | $14K | Sell |
|
|||||
|
2020
Q2 | $14K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $18K | Sell |
|
|||||
|
2019
Q3 | $42K | Sell |
|
|||||
|
2019
Q2 | $47K | Sell |
|
|||||
|
2019
Q1 | $62K | Buy |
|
|||||
|
2018
Q4 | $31K | Sell |
|
|||||
|
2018
Q3 | $151K | Buy |
|
|||||
|
2018
Q2 | $132K | Sell |
|
|||||
|
2018
Q1 | $186K | Buy |
|
|||||
|
2017
Q4 | $137K | Buy |
|
|||||
|
2017
Q3 | $86K | Buy |
|
|||||
|
2017
Q2 | $80K | Buy |
|
|||||
|
2017
Q1 | $84K | Buy |
|
|||||
|
2016
Q4 | $88K | Buy |
|
|||||
|
2016
Q3 | $55K | Hold |
|
|||||
|
2016
Q2 | $37K | Buy |
|
|||||
|
2016
Q1 | $37K | Buy |
|